ARTICLE | Company News
AVI BioPharma names Garabedian CEO
December 14, 2010 1:45 AM UTC
AVI BioPharma Inc. (NASDAQ:AVII) named Chris Garabedian, a director, as president and CEO, effective Jan. 1. He is the former VP of corporate strategy at Celgene Corp. (NASDAQ:CELG). Garabedian replac...